does the body make glp 1 GLP-1 for Weight Loss and Diabetes GLP-1 Drugs & What They
Description
Learn how GLP-1 weight loss programs may support heart health during American Heart Month

military, veterans, teachers, nurses and first responders the ability to benefit from
Having daily or weekly injections of GLP-1 agonists such as Ozempic and Wegovy may become a thing of the past for people with diabetes if a new drug delivery system proves effective in humans.

Many therapy areas had high growth in days of therapy in 2023 led by GLP-1 agonists driving obesity and diabetes. As the bar chart clearly tells us from the 3rd line on the bottom of the graph, obesity leads the top 30 therapy areas by growth from 2022

As part of this shift, Blue Cross Blue Shield of Michigan (Medicare) will now require members to start with Liraglutide, followed by step therapy before accessing other GLP-1s such as Ozempic or Wegovy
Discover the growth forecasts, key ingredients, and global NPD shaping this new $3.5bn category.
